Skip to main content
. 2022 Jun 10;10:89. doi: 10.1186/s40168-022-01270-7

Fig. 4.

Fig. 4

Metabolomic profiling of allogeneic HSCT patients at baseline versus Healthy controls. a) PCA between unmatched healthy controls (n=9) and patient baseline samples (n=53). b) An OPLS-DA coefficients plots of the model comparing healthy controls to baseline HSCT samples. Significant peaks are coloured. c) Butyrate correlates to alpha diversity at baseline (n=43) (R=0.38; p=0.01)